Alnylam Pharmaceuticals Inc (ALNY) Stock | Share Price | News
ALNY · Health Care ·
United States
Alnylam Pharmaceuticals Inc (ALNY) is a company in the Health Care sector, based in United States. The stock is held in 20 ETFs we track – with its largest weight of 0.49 % in XUHC (msci-usa-health-care). That means you can hold Alnylam Pharmaceuticals Inc indirectly and diversified through an ETF savings plan.
Above-average ETF coverage: 20 of the 95 ETFs we cover hold Alnylam Pharmaceuticals Inc, spread across 10 indices. That puts the stock in more ETFs than 84.5 % of the 4,362 stocks we cover.
Price chart
Performance
| Year to date | -40.3 % | 1 year | -47.0 % |
|---|---|---|---|
| 1 month | -14.2 % | 3 months | -19.2 % |
| Calendar year 2025 | +69.0 % | ||
| Calendar year 2026 | -39.9 % |
Risk metrics
Correlated with
The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.
| Instrument | r | −1 … +1 |
|---|---|---|
| Fair Isaac Corporation | +0.49 | |
| Altria Group Inc. | +0.45 | |
| L3Harris Technologies Inc | +0.44 | |
| Markel Group Inc. | +0.42 | |
| Xylem Inc. | +0.41 | |
| C.H. Robinson Worldwide Inc. | +0.40 | |
| RLC | -0.51 | |
| EMCOR Group Inc. | -0.48 | |
| Microsoft Corporation | -0.47 |
Key financials
Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY2023 | 1.8 | -0.4 | -24.1 % |
| FY2024 | 2.2 | -0.3 | -12.4 % |
| FY2025 | 3.7 | 0.3 | 8.4 % |
Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| XUHC | msci-usa-health-care | 0.49 % |
| XUHL | msci-usa-health-care | 0.49 % |
| SPFS | msci-world-health-care | 0.36 % |
| XDWH | msci-world-health-care | 0.36 % |
| XDEB | msci-world-minimum-volatility | 0.16 % |
| EXXT | nasdaq-100 | 0.14 % |
| 2B7K | msci-world-sri | 0.14 % |
| XNAS | nasdaq-100 | 0.14 % |
| XD9U | msci-usa | 0.05 % |
| XD9D | msci-usa | 0.05 % |
| SPYI | msci-acwi-imi | 0.04 % |
| SPSA | msci-acwi-imi | 0.04 % |
| EUNL | msci-world | 0.03 % |
| XDWD | msci-world | 0.03 % |
| SPPW | msci-world | 0.03 % |
| IUSQ | msci-acwi | 0.03 % |
| SPYY | msci-acwi | 0.03 % |
| XDWL | msci-world | 0.03 % |
| WIMI | msci-world-imi | 0.03 % |
| SWWD | msci-world | 0.03 % |
Want to know how much Alnylam Pharmaceuticals Inc overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Alnylam Pharmaceuticals Inc — the figure counts the ETFs holding both.
- Neurocrine Biosciences Inc.NBIX · 17 shared ETFs
Amgen Inc.AMGN · 20 shared ETFs
Vertex Pharmaceuticals IncorporatedVRTX · 20 shared ETFs
Regeneron Pharmaceuticals Inc.REGN · 19 shared ETFs
Gilead Sciences Inc.GILD · 20 shared ETFs
Illumina Inc.ILMN · 16 shared ETFs
Insmed IncorporatedINSM · 16 shared ETFs- Medline Inc. Class AMDLN · 16 shared ETFs
Latest Investment Intelligence News: Stocks
· MixedPOL tumbles 9.4% – August 26, 2026
· MixedSTX climbs 12.6% – August 25, 2026
· Risk-offSelling pressure hits markets, with only 30% of assets higher – August 24, 2026
· MixedCrypto, commodities & FX this week: Sui -9.0% · August 17–21, 2026
· MixedThe week in markets: MSCI Emerging Markets sets the tone for the week (+1.6%) · August 17–21, 2026